(Q44517551)

English

Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic study

scientific article published on 16 June 2003

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Increased VLDL-apoB and IDL-apoB production rates in nonlipodystrophic HIV-infected patients on a protease inhibitor-containing regimen: a stable isotope kinetic study (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1 reference

based on heuristic

inferred from title

author name string

Jean Michel Petit

1

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Michel Duong

2

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Emmanuel Florentin

3

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Laurence Duvillard

4

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Pascal Chavanet

5

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Jean Marcel Brun

6

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Henri Portier

7

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Philippe Gambert

8

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Bruno Verges

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

publication date

16 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Journal of Lipid Research

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

44

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

1692-1697

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Decrease of HIV-1 RNA levels in lymphoid tissue and peripheral blood during treatment with ritonavir, lamivudine and zidovudine. Ritonavir/3TC/ZDV Study Group

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

HIV-1 protease inhibitors induce an increase of triglyceride level in HIV-infected men without modification of insulin sensitivity: a longitudinal study.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Antiretroviral therapy-associated hyperlipidaemia in HIV disease

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Role of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Early kinetic abnormalities of apoB-containing lipoproteins in insulin-resistant women with abdominal obesity.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Atherogenesis: a postprandial phenomenon

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

HIV protease inhibitors stimulate hepatic triglyceride synthesis.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

The HIV protease inhibitor ritonavir increases lipoprotein production and has no effect on lipoprotein clearance in mice.

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Reversal of atherogenic lipoprotein profile in HIV-1 infected patients with lipodystrophy after replacing protease inhibitors by nevirapine

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Metabolic effects of indinavir in healthy HIV-seronegative men

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Significant improvement of apolipoprotein B-containing lipoprotein metabolism by insulin treatment in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300041-JLR200

21 January 2018

Identifiers

10.1194/JLR.M300041-JLR200

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44517551&oldid=2026605074"